NMD Pharma A/S
Latest round
- Series B
Last raised
- Nov 2023
Total raised
- $131M
Investors
- 6
About NMD Pharma A/S
Founded in 2015 and headquartered in Aarhus, Denmark, NMD Pharma A/S specializes in the development of therapeutics for neuromuscular disorders.NMD Pharma specializes in the discovery and development of innovative therapeutics aimed at treating neuromuscular diseases. The company’s primary focus is on small molecule inhibitors targeting skeletal muscle-specific ClC-1 ion channels, which are implicated in conditions characterized by muscle weakness and fatigue, such as myasthenia gravis, spinal muscular atrophy, Charcot-Marie-Tooth disease, and sarcopenia. These products aim to enhance muscle function and improve the quality of life for patients suffering from these debilitating conditions. The end users of their products are primarily patients diagnosed with neuromuscular disorders, while healthcare providers and institutions serve as clients, facilitating the delivery of these advanced treatment options. Revenue generation for NMD Pharma is expected to come from partnerships with healthcare providers and pharmaceutical distributors, as well as potential collaborations with larger pharmaceutical companies for further development and commercialization of its products. The company plans to expand its market presence in Europe and North America as it progresses through clinical trials, seeking to address the global need for effective treatments in the field of neuromuscular diseases.
Who invested in NMD Pharma A/S
6 investors across 3 rounds
See all investors in NMD Pharma A/S
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NMD Pharma A/S
Who invested in NMD Pharma A/S?
NMD Pharma A/S has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NMD Pharma A/S raised?
NMD Pharma A/S has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did NMD Pharma A/S last raise money?
NMD Pharma A/S's most recent round on record is a Series B, in Nov 2023.
What does NMD Pharma A/S do?
Founded in 2015 and headquartered in Aarhus, Denmark, NMD Pharma A/S specializes in the development of therapeutics for neuromuscular disorders.
Where is NMD Pharma A/S headquartered?
NMD Pharma A/S is headquartered in Aarhus, Denmark.
Which VCs invest in companies like NMD Pharma A/S?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at NMD Pharma A/S's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like NMD Pharma A/S? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.